Form 4 for MXCT MAXCYTE, INC.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-10-01 · accession 0001415889-24-024454 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-02 | 2024-10-01+ | MXCT | Erck Stanley C | Dir | S - Sale+OE | $3.75 | -47.7K | 269.1K | -15% | -$178.8K |
| DM | 2024-10-02 | 2024-10-01+ | MXCT | Erck Stanley C | Dir | M - OptEx | $0.04 | +47.7K | 295.2K | +19% | +$1,908 |
| DM | 2024-10-02 | 2024-10-01+ | MXCT | Erck Stanley C | Dir | M - OptEx | $0.00 | -47.7K | 47.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | S | D | 26,082 | $3.78 | 269,118 | D | — | — | (F2) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $3.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-10-02 | M | A | 21,607 | $0.04 | 290,725 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-01 | M | A | 26,082 | $0.04 | 295,200 | D | — | — | |
| 4 | Common | Common Stock | 2024-10-02 | S | D | 21,607 | $3.71 | 269,118 | D | — | — | (F3) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.625 to $3.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2024-10-01 | M | D | 26,082 | $0.00 | 69,296 | D | $0.04 · — to 2024-11-11 | 26,082 Common Stock | (F4) This option is fully vested and exercisable. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2024-10-02 | M | D | 21,607 | $0.00 | 47,689 | D | $0.04 · — to 2024-11-11 | 21,607 Common Stock | (F4) This option is fully vested and exercisable. |